|1.||Antzelevitch, Charles: 8 articles (01/2016 - 01/2005)|
|2.||Belhassen, Bernard: 8 articles (12/2015 - 09/2004)|
|3.||Viskin, Sami: 6 articles (12/2015 - 09/2004)|
|4.||Huang, Christopher L-H: 5 articles (06/2012 - 01/2007)|
|5.||Pope, Laura E: 4 articles (11/2014 - 05/2006)|
|6.||Borggrefe, Martin: 4 articles (06/2007 - 01/2005)|
|7.||Wolpert, Christian: 4 articles (06/2007 - 01/2005)|
|8.||Schimpf, Rainer: 4 articles (06/2007 - 01/2005)|
|9.||Glick, Aharon: 3 articles (12/2015 - 09/2004)|
|10.||Arguin, Paul M: 3 articles (10/2015 - 07/2010)|
10/01/1990 - "Thus, quinidine treatment is more effective than no antiarrhythmic therapy in suppressing recurrences of atrial fibrillation but appears to be associated with increased total mortality."
09/01/2005 - "Quinidine is effective for treatment of atrial fibrillation (AF) in horses, but often accelerates ventricular response rate. "
12/01/2001 - "Oral quinidine was safe and effective in the conversion of persistent atrial fibrillation to sinus rhythm."
04/15/1984 - "Intravenous quinidine therapy was a safe and effective means of converting the acute onset of atrial fibrillation to normal sinus rhythm in anesthetized horses."
04/01/1973 - "Electrocardiography for diagnosis and control of efficacy of oral quinidine sulfate in a case of atrial fibrillation in a Holstein cow."
07/01/2012 - "Vasospastic angina with J-wave pattern and polymorphic ventricular tachycardia effectively treated with quinidine."
04/01/1995 - "Nineteen patients with inducible ventricular tachycardia underwent serial electrophysiologic studies for evaluation of quinidine efficacy. "
08/01/1992 - "Isointegral ECG body surface mapping was performed in 51 patients with inducible ventricular tachycardia having programmed stimulation studies at baseline and after oral quinidine therapy. "
12/01/1984 - "Intravenous quinidine by intermittent bolus for electrophysiologic studies in patients with ventricular tachycardia."
04/01/2013 - "Premature ectopic beats and monomorphic ventricular tachycardia were observed in 50% of quinidine-treated heart preparations. "
03/01/2009 - "The long-term reproducibility of the EP efficacy of quinidine in patients with idiopathic VF and Brugada syndrome is excellent. "
01/01/2013 - "We report two cases of Brugada syndrome that presented with electrical storm and were treated successfully with oral quinidine, an "endangered species" drug. "
09/28/2004 - "Efficacy of quinidine in high-risk patients with Brugada syndrome."
12/01/2015 - "Quinidine in Brugada Syndrome: Still a Long Way to Go…."
07/01/2013 - "To examine the effectiveness of WK, alone and in combination with quinidine, to suppress arrhythmogenesis in an experimental model of Brugada syndrome (BrS). "
|4.||Cardiac Arrhythmias (Arrythmia)
11/15/2013 - "Among them one compound showed characteristics similar to quinidine in different arrhythmia models as well as electrocardiogram (ECG) studies which suggests that it possesses not only α1-adrenoceptor blocking properties but also affinity for cardiac Na(+) and K(+) channels, similar to class IA antiarrhythmic agents. "
02/01/2007 - "The aim of this study was to evaluate the pharmacokinetics and pharmacodynamics of quinidine-induced QT prolongation in healthy Caucasian and Korean subjects to investigate interethnic differences in susceptibility to drug-induced arrhythmia. "
12/15/2015 - "Gender had no influence on arrhythmia recurrence: 1 year after quinidine initiation, Kaplan-Meier probability of freedom from recurrent arrhythmia was 62.4% in men and 57.9% in women (p = 0.33). "
12/15/2015 - "Time to quinidine discontinuation and arrhythmia recurrence were evaluated using Cox proportional hazards models. "
03/01/2014 - "The case highlights the importance of quinidine for management of ventricular arrhythmias in the context of early repolarisation and suggests that J wave amplitude may be an important indicator of therapeutic drug levels and arrhythmia susceptibility. "
05/01/2005 - "In 1 patient, quinidine was effective in eliminating both ST-segment elevation and repetitive tachyarrhythmia episodes. "
09/01/2012 - "Oral quinidine therapy converted the tachyarrhythmia to sinus rhythm. "
03/01/2011 - "In five of six hearts, 10 μM quinidine slowed the frequency but did not terminate the tachyarrhythmia. "
10/01/2006 - "Quinidine proved to be efficient in prolonging the QT interval and rendering ventricular tachyarrhythmias non-inducible in patients with a mutation in KCNH2 (HERG). "
10/01/2005 - "Furthermore, in patients with a mutation in HERG (SQT1), quinidine rendered ventricular tachyarrhythmias noninducible and restored the QT interval/heart rate relationship toward a reference range. "
|7.||Sotalol (Sotalol Hydrochloride)
|1.||Electric Countershock (Cardioversion)
|3.||Drug Therapy (Chemotherapy)
|4.||Implantable Defibrillators (Implantable Cardioverter-Defibrillator)